A novel urinary metabolite signature for diagnosing major depressive disorder.
about
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderUrinary Biomarkers of Brain DiseasesStandardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a reviewUrinary N-methylnicotinamide and β-aminoisobutyric acid predict catch-up growth in undernourished Brazilian children.Novel urinary metabolite signature for diagnosing postpartum depressionPurinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.Alterations in the Vaginal Microbiome by Maternal Stress Are Associated With Metabolic Reprogramming of the Offspring Gut and Brain.Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies.Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.Current state of biomarkers in bipolar disorder.Stress transgenerationally programs metabolic pathways linked to altered mental health.Short overview on metabolomic approach and redox changes in psychiatric disorders.Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism.IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan cataboliteBiochemical effects of venlafaxine on astrocytes as revealed by 1H NMR-based metabolic profiling.A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis.2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.Sex differences in gut microbiota in patients with major depressive disorder.Omega-3 Fatty acids as Monotherapy in Treating Depression in Pregnant Women: a Meta- Analysis of Randomized Controlled Trials.Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex.Urinary biomarker panel for diagnosing patients with depression and anxiety disordersGC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old ageShort Term Intrarectal Administration of Sodium Propionate Induces Antidepressant-Like Effects in Rats Exposed to Chronic Unpredictable Mild StressDetermination of 4-Hydroxyphenyllactic Acid in Human Urine by Magnetic Solid-Phase Extraction and High-Performance Anion-Exchange Chromatography with Fluorescence DetectionBlood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
P2860
Q26747511-FD981198-E7F1-440F-ABEC-DBE59989D88FQ26769944-E579D7FF-9C71-4F21-9456-395B1D0CD3DCQ28083342-77AD1C46-D0FF-4E9A-9B9F-790761895EF6Q30277666-58A8D91D-4B06-41AA-9AAD-C12DF7B21912Q33704082-D14EC873-0503-475A-864D-83D50995ABA5Q34674792-2DE6EB82-9D6B-451E-97AA-011B3E57991BQ35665025-B50A3BFC-86D3-4E7A-A5FD-C8C71D749EC4Q37200180-1E776A6F-FAC1-4146-9CA2-15E423AA3C29Q37398383-5E189E36-B6A8-4126-A38E-F09643C0033EQ37648213-03788D5A-E109-4ECB-8F54-58E1766F8545Q37733240-22D7668F-71B2-4805-B9B6-A6D4CA95DD57Q38259465-DD03F8DC-49B3-4840-9FB4-59103063FD41Q38808013-7781CD05-7A95-4D7F-B62E-860D560738CDQ41791000-C2D0D668-7F5D-4441-9212-D77B64A542D7Q46565524-31A27C6E-CAAE-40A5-A40E-0E079F188B8CQ47860937-03E119A4-358D-4623-8B93-E1B53056D5DAQ48001597-8BE87CFA-C347-4F25-8619-45DD3DCC2350Q48050618-33C6E75A-DE39-447B-A439-DA88DACD858DQ50663896-2EDA43A8-42BA-4D89-B30B-1DCD41DA4ACAQ52665670-44AE2991-AE0E-41D4-8687-D999F25ADF6CQ52879696-EE0E4E6E-45FC-4DEC-8DC0-CB537F59FB18Q55002056-176ABF68-0624-4EC9-B7CC-B4EC847437B3Q57155162-E7C85D1B-AD76-44D3-A0D6-28EC8FE40068Q57161916-5EAEC1BC-6C88-47CC-8603-C121BF4C26F7Q57491015-5A5C38A0-73DA-4F8C-BBE3-AA70B8136EA6Q58128301-D73AB9CE-5667-4000-A082-1F38A0B4A877Q58554187-AD7E53E8-49F2-4105-90D8-B8C17C1B6256
P2860
A novel urinary metabolite signature for diagnosing major depressive disorder.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A novel urinary metabolite signature for diagnosing major depressive disorder.
@en
A novel urinary metabolite signature for diagnosing major depressive disorder.
@nl
type
label
A novel urinary metabolite signature for diagnosing major depressive disorder.
@en
A novel urinary metabolite signature for diagnosing major depressive disorder.
@nl
prefLabel
A novel urinary metabolite signature for diagnosing major depressive disorder.
@en
A novel urinary metabolite signature for diagnosing major depressive disorder.
@nl
P2093
P356
P1476
A novel urinary metabolite signature for diagnosing major depressive disorder.
@en
P2093
Jian-jun Chen
Lin-ke Zhou
Mei-xue Dong
Ming-ju Wang
Peng Zheng
Ting Huang
Yuan-jun Huang
P304
P356
10.1021/PR400939Q
P577
2013-11-26T00:00:00Z